Monkeypox Vax Maker Bavarian Nordic ‘No Longer Certain’ It Can Meet Demand as Cases Surge: Report

Monkeypox Vax Maker Bavarian Nordic ‘No Longer Certain’ It Can Meet Demand as Cases Surge: Report
A health care worker prepares a dose of the JYNNEOS monkeypox vaccine at a pop-up vaccination clinic in Los Angeles, Calif., on Aug. 9, 2022. Patrick T. FALLON/AFP via Getty Images
Katabella Roberts
Updated:
0:00

Monkeypox vaccine maker Bavarian Nordic has warned it may not be able to meet demand as cases of the virus continue to surge across the globe.

“It’s a very dynamic market situation,” Rolf Sass Sorensen, a vice president at the firm, told Bloomberg on Wednesday. “Demand keeps rising, and it’s no longer certain that we can continue to meet the demand we’re facing even with the upgrade of our existing manufacturing site in Denmark.”
Katabella Roberts
Katabella Roberts
Author
Katabella Roberts is a news writer for The Epoch Times, focusing primarily on the United States, world, and business news.
Related Topics